Evidence map›Paper›PMID 33872331›Full record

ArticlePLoS pathogens2021

Plasmacytoid dendritic cells have divergent effects on HIV infection of initial target cells and induce a pro-retention phenotype.

Orion Tong, Gabriel Duette, Thomas R O'Neil, Caroline M Royle, Hafsa Rana, Blake Johnson, Nicole Popovic, Suat Dervish, Michelle A E Brouwer, Heeva Baharlou and 8 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Orion TongCentre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.ORCID 0000-0002-0659-5944
Gabriel DuetteCentre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.ORCID 0000-0002-0295-8998
Thomas R O'NeilCentre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.
Caroline M RoyleCentre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.ORCID 0000-0002-4746-4297
Hafsa RanaCentre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.ORCID 0000-0002-4288-8859
Blake JohnsonCentre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.ORCID 0000-0002-7006-8495
Nicole PopovicCentre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.
Suat DervishWestmead research Hub, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.ORCID 0000-0001-7979-578X
Michelle A E BrouwerCentre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.ORCID 0000-0003-4265-0098
Heeva BaharlouCentre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.ORCID 0000-0001-8259-1059
Ellis PatrickCentre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.ORCID 0000-0002-5253-4747
Grahame CterctekoCentre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.
Sarah PalmerCentre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.
Eunok LeeCentre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.ORCID 0000-0002-5528-3859
Eric HunterEmory Vaccine Centre, Atlanta, Georgia, United States of America.ORCID 0000-0002-4273-8631
Andrew N HarmanCentre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.ORCID 0000-0003-1535-1279
Anthony L CunninghamCentre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.
Najla NasrCentre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.ORCID 0000-0001-6249-9204

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
Virologic Correlates of Heterosexual TransmissionR01AI051231 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ALLEN, TODD M, HUNTER, ERIC · 2002 to 2022
$9.9M
NIAID NIH HHS R01 AI051231NIH HHS P51 OD011132
6 · The paper itself

Abstract

Although HIV infection inhibits interferon responses in its target cells in vitro, interferon signatures can be detected in vivo soon after sexual transmission, mainly attributed to plasmacytoid dendritic cells (pDCs). In this study, we examined the physiological contributions of pDCs to early HIV acquisition using coculture models of pDCs with myeloid DCs, macrophages and the resting central, transitional and effector memory CD4 T cell subsets. pDCs impacted infection in a cell-specific manner. In myeloid cells, HIV infection was decreased via antiviral effects, cell maturation and downregulation of CCR5 expression. In contrast, in resting memory CD4 T cells, pDCs induced a subset-specific increase in intracellular HIV p24 protein expression without any activation or increase in CCR5 expression, as measured by flow cytometry. This increase was due to reactivation rather than enhanced viral spread, as blocking HIV entry via CCR5 did not alter the increased intracellular p24 expression. Furthermore, the load and proportion of cells expressing HIV DNA were restricted in the presence of pDCs while reverse transcriptase and p24 ELISA assays showed no increase in particle associated reverse transcriptase or extracellular p24 production. In addition, pDCs also markedly induced the expression of CD69 on infected CD4 T cells and other markers of CD4 T cell tissue retention. These phenotypic changes showed marked parallels with resident memory CD4 T cells isolated from anogenital tissue using enzymatic digestion. Production of IFNα by pDCs was the main driving factor for all these results. Thus, pDCs may reduce HIV spread during initial mucosal acquisition by inhibiting replication in myeloid cells while reactivating latent virus in resting memory CD4 T cells and retaining them for immune clearance.

Indexed as

CD4-Positive T-LymphocytesDendritic CellsFlow CytometryHIVHIV Core Protein p24HIV InfectionsHumansInterferon-alphaMyeloid CellsPhenotypeHIV Core Protein p24Interferon-alpha

Identifiers

PMID33872331
PMCPMC8084337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.